Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Atrix submits IND for new dosage form of Eligard

Aug. 8, 2002

Patient enrollment completed for phase III clinical trial with Tarceva

Aug. 7, 2002

Potential role for CEP-701 in the treatment of acute myeloid leukemia

Aug. 7, 2002

Novel topoisomerase I inhibitors in Advanced Life Sciences pipeline

Aug. 6, 2002

MTC-DOX designated orphan drug in E.U.

Aug. 6, 2002

Xyotax enters phase II trial in breast cancer

Aug. 6, 2002

Antitumor compound from natural source identified at Pharma Mar

Aug. 5, 2002

New CDK inhibitors emerge from Pharmacia R&D

Aug. 5, 2002

New data on the antitumor effects of the monoclonal antibody IMC-C225

Aug. 5, 2002

P&G scientists describe novel benzimidazole with antitumor/antiviral activity

Aug. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...